APC amicus brief addresses ambiguity in FDA insanitary conditions guidance

APC engaged in the matter because we were—and remain—concerned about the significant implications on other APC-member compounding pharmacies if FDA continues to impose what appears to be vague, subjective disciplinary standards. read more →
Our list of PFMs keeps going (and growing)

APC offers a pharmacy/facility membership (PFM) as an alternative to purchasing several individual memberships. This is a relatively new program, so we'd like to thank our 38 PFM members so far for being the trailblazers they are. read more →
Avoid becoming an insurance statistic, a $25 webinar from APC

Thanks to our friends at Pharmacists Mutual, we can tell you and your team members what they are and how to avoid them. read more →
APC and CVM leaders meet (again)

In a recent follow-up meeting with APC leaders, FDA’s Center for Veterinary Medicine’s Dr. Bill Flynn acknowledged APC's questions about the practical implications of certain provisions of GFI256 may result in tweaks to the doc. read more →
APC Fellows Program gets 2022 reboot

Established in 1997, the APC Fellows Program distinguishes pharmacists—and, new this year, pharmacy technicians—who are exemplary in their professionalism and commitment to the practice of pharmacy compounding. read more →
Upcoming programs: Compounding Pharmacy Compliance and two webinars

Registration is open for Informa Connect's hybrid conference, Compounding Pharmacy Compliance, June 21-22, 2022, at the Hilton Alexandria Mark Center in Alexandria, VA. read more →
Thanks for the memories, Mr. Kantor

The APC Team recently said goodbye to our outgoing director of communications, Andrew Kantor, whose last day was Thursday, May 12. read more →
APC, CVM leaders meet, discuss GFI #256

On Wednesday, APC leaders met with officials from FDA’s Center for Veterinary Medicine to enunciate concerns about what APC sees as ambiguity and uncertainty in CVM’s final GFI #256, regarding animal compounding. read more →
PCAC to consider glutathione

This just in: FDA’s Pharmacy Compounding Advisory Committee will meet June 8, when a number of substances will be up for review, notably glutathione. read more →